— Cardinal Health (NYSE: CAH) reported second-quarter 2020 non-GAAP EPS attributable to the company of $1.52 vs. $1.22 expected.
— Revenue increased 5% to $39.7 billion vs. $39.43 billion expected.
— GAAP EPS attributable to the company decreased to $0.75 from $0.93 in the second quarter of 2019.
— For FY20, Cardinal Health lifted non-GAAP EPS attributable to the company outlook to a range of $5.20 to $5.40 from the previous range of $4.85 to $5.10.
— Pharmaceutical segment revenue increased 6% year-over-year to $35.7 billion.
— Medical segment revenue was flat with prior-year-quarter at $4 billion.
— CAH stock rose about 6% in the pre-market trading session.
Most Popular
Earnings Preview: What to look for when Kroger (KR) reports Q1 2025 results
The Kroger Co. (NYSE: KR) is expected to report its first-quarter financial results next week. Customer engagement remained stable last year, driven by high-quality products and tailored promotional offers. Recently,
Adobe (ADBE) Q2 adjusted earnings rise on higher revenues
Adobe Inc. (NASDAQ: ADBE) on Thursday reported an increase in revenue and adjusted profit for the second quarter of 2025, amid continued growth in its subscription-based business. The design software
ORCL Earnings: Highlights of Oracle’s Q4 2025 financial report
Technology giant Oracle Corporation (NYSE: ORCL) has reported higher revenues and adjusted earnings for the fourth quarter of 2025. Total revenues increased to $15.9 billion in the May quarter from
